As of August 2019 , almost 30 percent of manufacturing facilities producing active pharmaceutical ingredients ( APIs ) were located in the United States . This relates to the manufacture of human drugs regulated by the U.S. Food and Drug Administration ( FDA ) for the U.S. market .
